Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases

13 Mar 2006

Abstract excerpt

The clinical diagnosis of major neurodegenerative disorders, e.g. Alzheimer's disease, Parkinson's disease, and dementia with Lewy body, remains unsatisfactory based on current clinical criteria and limited laboratory investigations. The possibility of identifying multiple novel biomarkers for neurodegenerative diseases, those related to disease pathogeneses in particular, has been greatly enhanced with recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Alzheimer's disease research and treatments
Share to Biotin and Related Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16556969
DOI: 10.3233/jad-2005-8407

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseasesPMID 16556969Read ↗

Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly.Semantic proximity Read ↗

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.Semantic proximity Read ↗

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.Semantic proximity Read ↗

Use of proteomic methods in the analysis of human body fluids in A lzheimer researchSemantic proximity Read ↗

Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisSemantic proximity Read ↗

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

The Use of Proteomics in Biomarker Discovery in Neurodegenerative DiseasesSemantic proximity Read ↗

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomicsSemantic proximity Read ↗

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of ProteomicsSemantic proximity Read ↗

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's diseaseSemantic proximity Read ↗

Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomasSemantic proximity Read ↗

Differential proteomic profile of lumbar and ventricular cerebrospinal fluidSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.